Compass therapeutics g
WebMar 12, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Rating) CEO Thomas J. Schuetz acquired 10,000 shares of the stock in a transaction on Friday, March 10th. The shares were acquired at an average price of $3.37 per share, for a total transaction of $33,700.00. Following the acquisition, the chief executive officer now owns 6,021,873 … WebApr 13, 2024 · Key Insights. Significantly high institutional ownership implies Compass Therapeutics' stock price is sensitive to their trading actions. 53% of the business is held by the top 9 shareholders
Compass therapeutics g
Did you know?
WebApr 12, 2024 · Insiders who bought Compass Therapeutics, Inc. (NASDAQ:CMPX) stock in the last 12 months were richly rewarded last week. The company's market value … WebApr 10, 2024 · The trading price of Compass Therapeutics Inc. (NASDAQ:CMPX) closed higher on Thursday, April 06, closing at $3.36, 3.07% higher than its previous close. …
WebBOSTON, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing … WebApr 11, 2024 · Compass Therapeutics Stock Up 2.4 %. NASDAQ:CMPX opened at $3.44 on Tuesday. Compass Therapeutics has a 52 week low of $1.30 and a 52 week high of …
WebApr 12, 2024 · Compass Therapeutics has a consensus target price of $9.05, suggesting a potential upside of 162.32%. Given Sutro Biopharma’s higher probable upside, analysts plainly believe Sutro Biopharma is ... WebStage 1: Infancy: Trust vs. Mistrust. Infants depend on caregivers, usually parents, for basic needs such as food. Infants learn to trust others based upon how well caregivers meet …
WebApr 11, 2024 · Compass Therapeutics Stock Up 2.4 %. NASDAQ:CMPX opened at $3.44 on Tuesday. Compass Therapeutics has a 52 week low of $1.30 and a 52 week high of $5.65. The company has a fifty day simple moving ...
WebDriving Directions to Tulsa, OK including road conditions, live traffic updates, and reviews of local businesses along the way. jbnsts full formWebApr 12, 2024 · The third cohort of the COMPASS trial confirmed the highest planned dose target for the study is well tolerated. ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, … jbnsts senior interview quoraWebNov 2, 2024 · Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. jbnthrhc是什么WebThe City of Fawn Creek is located in the State of Kansas. Find directions to Fawn Creek, browse local businesses, landmarks, get current traffic estimates, road conditions, and … luther mathews otienoWebMay 14, 2011 · Compass Therapeutics Inc. Report this profile Report Report. Back Submit. About I am a committed experimentalist, team leader and mentor, who has a sincere passion for biomedical research, high ... luther mateusWebApr 10, 2024 · The trading price of Compass Therapeutics Inc. (NASDAQ:CMPX) closed higher on Thursday, April 06, closing at $3.36, 3.07% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.25 and $3.46. In examining the 52-week price action we see that the stock hit a 52 … luther massive attackWebApr 11, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) has earned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, MarketBeat reports ... luther matney